A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Abstract
Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15(INK4b) and p21(CIP1). Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling. The inflammasome and IL-1 signalling are activated in senescent cells and IL-1α expression can reproduce SASP activation, resulting in senescence. Our results demonstrate that the SASP can cause paracrine senescence and impact on tumour suppression and senescence in vivo.
Overview
CoChat Summary
## TL;DR
Cells undergoing oncogene-induced senescence (OIS) can transmit senescence to neighboring normal cells through secreted SASP factors, creating a stable paracrine senescence state in culture and in vivo. The paper identifies TGFβ family ligands and IL-1/inflammasome signaling as key regulators of this process.
## Key findings
- Normal IMR90 fibroblasts and HMECs became growth-arrested when co-cultured with OIS cells; the effect was transmitted through transwells and conditioned media, showing it was mediated by soluble factors rather than direct contact.
- Paracrine senescence resembled full senescence: normal cells showed increased DNA/oxidative damage, p16^INK4a^, p21^CIP1^, and SASP markers; gene-expression profiles of OIS and paracrine senescence were highly correlated and clustered together.
- Quantitative proteomics and a 78-compound screen implicated multiple SASP components in paracrine senescence, including TGFβ family ligands, VEGF, CCL2, and CCL20; blocking VEGFR2/FLT3, TGFBR1, or CCR2 partially impaired the arrest.
- The paper reports specific in vivo evidence of paracrine senescence: p21^CIP1^+/p16^INK4a^ cells were found near OIS lesions in mouse liver and skin, and in human serrated sessile adenomas the stromal p21^CIP1^/Ki-67^- signal was significantly increased near lesions (p = 0.03), with a separate comparison reporting p = 4.6 × 10^-5^ for p21^CIP1^ positive/Ki67 negative stromal cells.
## Methods
- Co-culture, transwell, conditioned-media, and cluster assays were used in human IMR90 fibroblasts and HMECs; OIS was induced with ER:RAS, MEK:ER, or related oncogenic constructs activated by 4OHT.
- Secretome analysis used SILAC-based quantitative proteomics, followed by a 78-compound receptor/pathway screen, RNAi knockdown, RT-qPCR, microarrays, GSEA, immunofluorescence/high-content analysis, and assays for BrdU, SA-β-Gal, caspase-1, and antibody arrays.
- In vivo validation used mouse OIS models including Nras-driven hepatocyte senescence, K5-Sos/Egfr^wa2/+^ skin papillomas, and Pdx1-Cre Kras^G12D^ pancreatic lesions, plus human SSA tissue IHC.
## Limitations
- The paper itself notes that “the nature of these cells and the functional implications of paracrine senescence remain open questions for future studies.”
- It also states that not all cells surrounding preneoplastic lesions undergo paracrine senescence; it proposes possible explanations such as soluble-factor gradients and cell-type susceptibility, but these are not experimentally resolved here.
- Evident from the text: many mechanistic and inhibitor results are partial (“partially rescued,” “partially prevented”), so the study does not identify a single exclusive mediator of paracrine senescence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 1 Not valid · 7 Not checked · 78 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“a transcriptional signature associated with senescence 18 was significantly upregulated during paracrine senescence (Fig 3d).”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence resembles a full senescence response
What the sources say
- Supportedcites [18] Fridman, A. L. & Tainsky, M. A. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene27, 5975–5987 (2008). source
The 'Genomic approaches to identify senescence/immortalization genes and pathways' section describes gene-expression profiling that identifies genes and pathways associated with senescence. In the citing sentence, the citation identifies the senescence-associated transcriptional signature; the finding that it was significantly upregulated during paracrine senescence is attributed to the citing paper’s Fig. 3d, not to this source. No page number is available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS 31,34,35 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence is observed in mouse and human models of OIS in vivo
What the sources say
- Partly supportedcites [31] Carragher, L. A. et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol. Med.2, 458–471 (2010). sourceExperimental — accuracy not yet measured
The Discussion reports V600E BRAF mutations in approximately 70% of right-sided serrated hyperplastic polyps and serrated adenomas, supporting a major role for BRAF in the serrated pathway. The Results show that V600E Braf induces senescence in mouse small-intestinal crypts, but do not establish that BRAF mutations trigger OIS in human colon sessile serrated adenomas. (LLM, conf=0.87)
- Partly supportedcites [34] Kriegl, L. et al. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer. Mod. Pathol.24, 1015–1022 (2011). sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that initiating BRAF mutations might drive oncogene-induced senescence in human serrated polyps, and concludes that the data provide evidence for senescence in the BRAF-mutated serrated route. It does not establish that colon sessile serrated adenomas are mainly driven by BRAF mutations: the study selected BRAF-mutated lesions for its final analysis, and its proposed causal link is hedged. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [35] Bennecke, M. et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell18, 135–146 (2010). source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A signature derived from IMR90 cells undergoing paracrine senescence is found enriched in mouse PANIN 44 and human serrated sessile adenomas (SSA) 36 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > REFERENCES
What the sources say
- Partly supportedcites [44] Ling, J. et al. KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell21, 105–120 (2012). sourceExperimental — accuracy not yet measured
The Results section, “Inhibition of Key Proinflammatory Cytokines,” reports gene-expression profiles from mouse PanIN, so this paper provides the mouse PanIN data cited as reference 44. It does not report testing or finding enrichment of an IMR90 paracrine-senescence signature in those profiles. The SSA finding is attached to a different citation (36), not this source. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [36] Caruso, M. et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Archiv.454, 291–302 (2009). source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
- Also stated in: § Abstract · plain
“Coupling quantitative proteomics with small molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling.”
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
54 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 21
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The senescent cell fate can be triggered by a number of stressors including DNA damage, cancerous mutations or oncogene activation, mitochondrial dysfunction, reactive metabolites, hyperoxia or hypoxia, proteotoxic stress, extracellular signals, infections, mechanical or shear stresses that deform cells, resistance exercise and factors secreted by other senescent cells18,38–47.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inflammasome, a multiprotein complex comprising caspase 1 and key regulators of the defence mechanisms against pathogens117, and Toll-like receptors, which regulate the inflammasome, have been reported to promote maturation and secretion of SASP factors during OIS73,118.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, specific SASP components, either soluble or in extracellular vesicles186, can induce senescence in a paracrine manner — which includes DDR activation73,83.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upstream signals triggering SASP activation are multiple and differ depending on the senescence inducer but include DNA damage, cytoplasmic chromatin fragments (CCFs) that trigger a type 1 interferon response, and damage-associated molecular patterns (DAMPs) that activate the inflammasome (Acosta et al., 2013; Davalos et al., 2013; Li and Chen, 2018).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher secretion of SASP factors is also associated with an enhanced immune response, leading to inflammation which may promote tumorigenesis (Acosta et al., 2013).”
From Single senescent cell sequencing reveals heterogeneity in senescent cells induced by telomere erosion (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measured
47 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 901–1,000 of 2,273
Teissier, T., Temkin, V., Pollak, R. D., & Cox, L. S. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.812157 · Cited by 39
“The SASP can drive bystander senescence (also known as secondary senescence) through a paracrine effect (Acosta et al., 2013).”
BackgroundCerebral Microvascular Senescence and Inflammation in Diabetes
Phoenix, A., Chandran, R., & Ergul, A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.864758 · Cited by 34
“Senescence is a biological process defined by an apoptosis-resistant and irreversible arrested cell cycle with a distinct pro-inflammatory phenotype affecting neighboring cells (Hayflick and Moorhead, 1961; Rodier and Campisi, 2011; Acosta et al., 2013; Childs et al., 2015; He and Sharpless, 2017).”
BackgroundInfluentialMamun, A. A., Sufian, M. A., Uddin, M. S., Sumsuzzman, D. M., Jeandet, P., Islam, M. S., Zhang, H., Kong, A. T., & Sarwar, M. S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174991 · Cited by 40
Du, H., Xiao, N., Zhang, S., Zhou, X., Zhang, Y., Lu, Z., Fu, Y., Huang, M., Xu, S., & Chen, Q. (2023) · iScience · doi:10.1016/j.isci.2023.107090 · Cited by 35
“Another feature of senescent cells is the SASP signature, characterized by the secretion of a distinct set of cytokines, chemokines, and metalloproteinases.(36) We examined the expression of representative SASP factors, including IL-1b, IL-6, IL-8, Mmp12 and p16 by reverse transcription quantitative polymerase chain r…”
BackgroundXia, J., He, S., Dai, Q., Jia, H., Ge, Y., Zhou, M., & Wang, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110465 · Cited by 38
Yang, H., Chen, X., Chen, J., Dong, Y., Huang, Y., Qin, L., Tan, J., & Yi, W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1492870 · Cited by 47
Senescence-Inflammatory Regulation of Reparative Cellular Reprogramming in Aging and Cancer
Menéndez, J. A., & Alarcón, T. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00049 · Cited by 34
“…as MMP3, growth factors such as HGF and TGFβ, inflammatory chemokines such as CCL2 and CLL11, and prominent proinflammatory cytokines such as IL1α/β, IL-6, and IL-8 (Coppé et al., 2008; Kuilman and Peeper, 2009; Orjalo et al., 2009; Rodier et al., 2009; Gross et al., 2012; Acosta et al., 2013).”
BackgroundCho, S., Kim, A. Y., Kim, J., Choi, D. H., Son, E., & Shin, D. W. (2019) · British Journal of Dermatology · doi:10.1111/bjd.17824 · Cited by 37
From Development to Aging: The Path to Cellular Senescence
Sacco, A., Belloni, L., & Latella, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8071 · Cited by 41
“The SASP can induce senescence in a paracrine manner in neighboring cells (3) and leads to reinforcement of cell cycle arrest by cytokines such as IL-6 or IL-8 (73).”
BackgroundWang, P., Konja, D., Singh, S., Zhang, B., & Wang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041978 · Cited by 42
“…growth modulators, matrix metalloproteinases, and compromised extracellular vesicles which represent senescence-associated phenotype, senescent cells reprogram the surrounding microenvironment and cause tissue damage, thus promoting ageing and the development of age-associated diseases [20,24–29].”
BackgroundFranco, A. C., Martini, H., Victorelli, S. G., Lagnado, A. B., Wyles, S. P., Rowsey, J. L., Pirius, N., Woo, S., Costa, D. G., Chaib, S., et al. (2024) · Aging Cell · doi:10.1111/acel.14340 · Cited by 38
Senolytic treatment for low back pain
Mannarino, M., Cherif, H., Darband, S. G., Martinez, O. W., Sheng, K., Cousineau, E., Lee, S., Millecamps, M., Gao, C., Gilbert, A., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr1719 · Cited by 37
“These chemokines have been suggested to induce ECM degradation, inflammatory response ( 50 , 98 – 100 ), and senescence ( 13 , 101 ).”
Subedi, S., Guntipally, M., Suwal, N., Thapa, R., Bashyal, S., Panth, N., Gupta, G., MacLoughlin, R. J., Oliver, B. G. G., Dua, K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102813 · Cited by 40
The role of EGFR signaling in age‐related osteoporosis in mouse cortical bone
Liu, G., Xie, Y., Su, J., Qin, H., Wu, H., Li, K., Yu, B., & Zhang, X. (2019) · The FASEB Journal · doi:10.1096/fj.201900436rr · Cited by 36
Martínez, J., Tarallo, D., Palma, L. M., Victoria, S., Bresque, M., Rodríguez-Bottero, S., Marmisolle, I., Escande, C., Cassina, P., Casanova, G., et al. (2019) · Biochemical Journal · doi:10.1042/bcj20190405 · Cited by 36
ROCK inhibition modulates the senescence‐associated secretory phenotype (SASP) in oral keratinocytes
Niklander, S. E., Bandaru, D., Lambert, D., & Hunter, K. D. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.13012 · Cited by 33
Ilie, O., Ciobica, A. S., Riga, S., Dhunna, N., McKenna, J., Mavroudis, I. A., Doroftei, B., Ciobanu, A. M., & Riga, D. (2020) · Medicina · doi:10.3390/medicina56110626 · Cited by 40
Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of Obesity
Moustakas, I. I., Katsarou, A., Legaki, A., Pyrina, I., Ntostoglou, K., Papatheodoridi, A., Gercken, B., Pateras, I. S., Gorgoulis, V. G., Koutsilieris, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073446 · Cited by 32
“SASP-related mediators affect the tissue microenvironment by attracting immune cells that are capable of removing senescent cells, whilst simultaneously acting as paracrine inducers of senescence in neighboring cells [1,3,4].”
BackgroundSenescent cells and SASP in cancer microenvironment: New approaches in cancer therapy
Özdemir, A., Demir, Y. D. Ş., Yeşilyurt, Z. E., & Ark, M. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.10.002 · Cited by 36
Cieslik, K. A., Trial, J., & Entman, M. L. (2015) · The FASEB Journal · doi:10.1096/fj.14-268136 · Cited by 34
“The aging fibroblast has been associated with a secretory phenotype (22).”
BackgroundHIV antiretroviral therapy drugs induce premature senescence and altered physiology in HUVECs
Cohen, J., D’Agostino, L., Tuzer, F., & Torres, C. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.07.008 · Cited by 31
“Some of these cytokines include IL-1α, IL-1β and IL-6 which is particularly interesting as they have been shown to induce senescence in neighboring cells in a paracrine manner (Acosta et al., 2013).”
Effects of HIV-1 gp120 and tat on endothelial cell sensescence and senescence-associated microRNAs
Hijmans, J. G., Stockleman, K., Reiakvam, W., Levy, M. V., Brewster, L. M., Bammert, T. D., Greiner, J. J., Connick, E., & DeSouza, C. A. (2018) · Physiological Reports · doi:10.14814/phy2.13647 · Cited by 31
“These and other senescence-associated cytokines can induce senescence in bystander endothelial cells and stimulate monocyte activation and infiltration through the vascular wall, promoting atherosclerotic lesion development (Acosta et al. 2013).”
BackgroundAirway Epithelium Senescence as a Driving Mechanism in COPD Pathogenesis
Bateman, G., Guo-Parke, H., Rodgers, A. M., Linden, D. A., Bailey, M., Weldon, S., Kidney, J. C., & Taggart, C. C. (2023) · Biomedicines · doi:10.3390/biomedicines11072072 · Cited by 44
“Excess oxidative stress and DNA damage also triggers the activation of the NLRP3 inflammasome, stimulating NF-κB and the IL-1β-mediated inflammatory cascade, thus further perpetuating the prolonged low-grade inflammatory response in COPD epithelium [4,84].”
BackgroundBranched‐Chain Amino Acid Accumulation Fuels the Senescence‐Associated Secretory Phenotype
Liang, Y., Pan, C. C., Yin, T., Wang, L., Gao, X., Wang, E., Quang, H., Huang, D., Tan, L., Xiang, K., et al. (2023) · Advanced Science · doi:10.1002/advs.202303489 · Cited by 44
Ali, I., Zhang, H., Zaidi, S. A. A., & Zhou, G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102273 · Cited by 41
Kim, S. Y., & Cheon, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102446 · Cited by 36
Therapy-induced microenvironmental changes in cancer
Ma, Y., Yang, H., Pitt, J. M., Kroemer, G., & Zitvogel, L. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1401-8 · Cited by 35
Maciel-Barón, L. Á., Morales-Rosales, S. L., Silva‐Palacios, A., Rodríguez‐Barrera, R., García, J. A., Luna‐López, A., Pérez, V., Torres, C. A., & Königsberg, M. (2018) · Biogerontology · doi:10.1007/s10522-018-9767-3 · Cited by 36
Interleukin-1α as an intracellular alarmin in cancer biology
Voronov, E., Dinarello, C. A., & Apte, R. N. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.10.006 · Cited by 37
Molecular basis of senescence transmitting in the population of human endometrial stromal cells
Griukova, A., Deryabin, P. I., Shatrova, A. N., Burova, E., Severino, V., Farina, A., Nikolsky, N. N., & Borodkina, A. V. (2019) · Aging · doi:10.18632/aging.102441 · Cited by 34
“Another outcome of the altered paracrine activity of senescent cells is that SASP may sensitize normal neighboring cells to senesce, accelerating propagation of senescence within cell population and contributing to tissue dysfunction [15].”
Rising from the ashes: cellular senescence in regeneration
Walters, H., & Yun, M. H. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.06.002 · Cited by 32
Feng, J., Li, B., Wang, X., Li, H., Chen, Y., Xiao, W., Li, Z., Xie, L., Lu, W., Jiang, H., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.12.012 · Cited by 33
Trionfetti, F., Marchant, V. A., Gónzalez-Mateo, G. T., Kawka, E., Márquez‐Expósito, L., Ortíz, A., López‐Cabrera, M., Ruiz‐Ortega, M., & Strippoli, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065763 · Cited by 36
Chojak, R., Fares, J., Petrosyan, E., & Lesniak, M. S. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04387-3 · Cited by 35
Caland, L., Labbé, P., Mamarbachi, M., Villeneuve, L. R., Ferbeyre, G., Noly, P., Carrier, M., Thorin‐Trescases, N., & Thorin, É. (2019) · Aging · doi:10.18632/aging.102020 · Cited by 37
“Furthermore, ANGPTL2 and p21 levels correlated with pro-inflammatory cytokines of the SASP, i.e ., TNFα , IL-8 and IL-6 levels (Figure 9B-C).”
BackgroundInfluentialRibosomal S6 kinase 1 regulates inflammaging via the senescence secretome
(2024) · doi:10.1038/s43587-024-00695-z · Cited by 31
Self-citationRibosomal S6 kinase 1 regulates ‘inflammaging’ via the senescence secretome
Gallage, S., Irvine, E. E., Pedroni, S. M. A., Barragan Avila, J. E., Khadayate, S., Pombo, J., Brookes, S., Heide, D., Dharmalingham, G., Choudhury, A. I., et al. (2023) · doi:10.1101/2023.10.17.562098 · Cited by 31
“Il1b is one of the cytokines more robustly regulated by S6K1 and plays a critical role in activating immune surveillance of senescent cells 41 .”
BackgroundSelf-citationRegulation of cellular senescence by microRNAs
Ma, X., Zheng, Q., Zhao, G., Yuan, W., & Liu, W. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111264 · Cited by 30
XPO7 is a tumor suppressor regulating p21CIP1-dependent senescence
Innes, A. J., Sun, B., Wagner, V., Brookes, S., McHugh, D., Pombo, J., Porreca, R. M., Dharmalingam, G., Vernia, S., Zuber, J., et al. (2021) · Genes & Development · doi:10.1101/gad.343269.120 · Cited by 30
“3C), a widely employed model of OIS (Acosta et al. 2013).”
MethodSelf-citationTelomeres: beacons of autocrine and paracrine DNA damage during skin aging
Victorelli, S. G., & Passos, J. F. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1728016 · Cited by 36
“been shown in humans, where stromal cells positive for p21 were observed in the vicinity of human colon sessile serrated adenomas (SSAs), pre-malignant lesions which result from BRAF mutations that trigger oncogene-induced senescence [6].”
BackgroundInfluentialRejuvenation of Mesenchymal Stem Cells to Ameliorate Skeletal Aging
Cheng, M., Yuan, W., Moshaverinia, A., & Yu, B. (2023) · Cells · doi:10.3390/cells12070998 · Cited by 38
“Finally, the inflammatory microenvironment caused by SASP from senescent MSCs can accelerate the senescence or induce apoptosis of neighboring cells [70].”
BackgroundYang, J.-J., Zhao, S.-L., Zhang, X., Ma, Y., & Jiang, J. (2023) · Industrial Crops and Products · doi:10.1016/j.indcrop.2023.116903 · Cited by 30
Senescence in Adipose-Derived Stem Cells: Biological Mechanisms and Therapeutic Challenges
Foti, R., Storti, G., Palmesano, M., Scioli, M. G., Fiorelli, E., Terriaca, S., Cervelli, G., Kim, B., Orlandi, A., & Cervelli, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158390 · Cited by 39
“Multiple constituents of the SASP can induce senescence in adjacent non-senescent cells, a phenomenon termed paracrine senescence [53].”
BackgroundOdeh, A., Dronina, M. A., Domankevich, V., Shams, I., & Manov, I. (2019) · Aging Cell · doi:10.1111/acel.13045 · Cited by 32
“SASP contributes to tissue repair and reinforcement of senescence in damaged cells (Acosta et al., 2013); however, it is involved in the maintenance of the pro‐inflammatory microenvironment, resulting in the acquisition of sterile inflammation, leading to age‐associated diseases including cancer…”
BackgroundJin, H., Zhang, Y., Liu, D., Wang, S. S., Ding, Q. J., Rastogi, P., Purvis, M., Wang, A., El-Hadi, S., Ren, C., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.09.013 · Cited by 34
Self-citationHan, X., Zhang, T., Zhang, X., Zhang, R., Lao, K., Mi, Y., & Gou, X. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111347 · Cited by 35
Zhang, N., Ji, J., Zhou, D., Liu, X., Zhang, X., Liu, Y., Xiang, W., Wang, M., Zhang, L., Wang, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020849 · Cited by 33
Lee, S. Y., Park, K. H., Lee, G., Kim, S., Song, W., Kwon, S., Koh, J., Huh, Y. H., & Ryu, J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00594-y · Cited by 33
Autophagy and senescence in cancer therapy
Patel, N. H., Bloukh, S., Alwohosh, E., Alhesa, A., Saleh, T., & Gewirtz, D. A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.002 · Cited by 42
Tinaburri, L., D’Errico, M., Sileno, S., Maurelli, R., Degan, P., Magenta, A., & Dellambra, E. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9147326 · Cited by 32
“Moreover, the inflammasome activation and IL-1β signaling reinforces paracrine senescence in several tissues [2, 100].”
Van houcke, J., Mariën, V., Zandecki, C., Ayana, R., Pepermans, E., Boonen, K., Seuntjens, E., Baggerman, G., & Arckens, L. (2023) · npj Regenerative Medicine · doi:10.1038/s41536-023-00304-4 · Cited by 29
“This SASP can also turn neighboring cells senescent in a process called paracrine senescence 34,35 .”
Valerio, H. P., Ravagnani, F. G., Ronsein, G. E., & Mascio, P. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-02658-5 · Cited by 38
Apoptosis signal-regulating kinase 1 promotes inflammation in senescence and aging
Odawara, T., Yamauchi, S., & Ichijo, H. (2024) · Communications Biology · doi:10.1038/s42003-024-06386-0 · Cited by 30
Uncovering key mechanisms and intervention therapies in aging skin
Zhang, Y., Liu, L., Yue, L., Huang, Y., Wang, B., & Liu, P. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.07.009 · Cited by 31
Zhang, Y., Xiao, B., Yuan, S., Ding, L., Pan, Y., Jiang, Y., Sun, S., Ke, X., Cai, L., & Jia, L. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103323 · Cited by 39
“Other SASP factors may also contribute to paracrine senescence and cause tumor suppression [80].”
BackgroundImmune aging and infectious diseases
Chen, R., Zou, J., Chen, J., Wang, L., Kang, R., & Tang, D. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003410 · Cited by 39
TGF‑β induces periodontal ligament stem cell senescence through increase of ROS production
Fan, C., Ji, Q., Zhang, C., Xu, S., Sun, H., & Li, Z. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10580 · Cited by 46
“Senescent cells usually produce a series of cytokines, chemokines, and other soluble factors, a phenotype called SaSP, which is believed to reinforce senescence (13,15).”
BackgroundDeng, B., Luo, Q., Halim, A., Liu, Q., Zhang, B., & Song, G. (2019) · DNA and Cell Biology · doi:10.1089/dna.2019.4877 · Cited by 32
“At the same time, HIF-1 a can have synergistic effects on the TGF-b signaling pathway to increase the transcription activity of VEGF , which accelerates tumor angiogenesis (Acosta et al. , 2013).”
Yoshioka, N., Tanaka, M., Ochi, K., Watanabe, A., Ono, K., Sawada, M., Ogi, T., Itoh, M., Ito, A., Shiraki, Y., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111738 · Cited by 30
Carpintero-Fernández, P., Borghesan, M., Eleftheriadou, O., Pan‐Castillo, B., Fafián‐Labora, J., Mitchell, T. P., Yuste, A., Öğrünç, M., Nightingale, T. D., Mayán, M. D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04569-3 · Cited by 32
“In line with these findings, senescent human primary fibroblasts also release proangiogenic factors such as VEGF [36].”
BackgroundCell Senescence and Central Regulators of Immune Response
Lunin, S. M., Novoselova, E. G., Glushkova, O. V., Parfenyuk, S. B., Novoselova, T. V., & Khrenov, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084109 · Cited by 31
“On the other hand, these factors can disrupt tissue homeostasis, contributing to the senescence of surrounding cells (paracrine ageing) [35], and chronic inflammation may lead to pathological conditions such as fibrosis and cancer [32].”
BackgroundRaynard, C., Tessier, N., Huna, A., Warnier, M., Flaman, J., Coppenolle, F. V., Ducreux, S., Martin, N., & Bernard, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169376 · Cited by 30
“overexpressing 4-OHT-inducible ER:Ras oncogene (transcriptome data [23]) or WI38 treated with”
BackgroundMethodKuehnemann, C., Hughes, J. B., Desprez, P., Melov, S., Wiley, C. D., & Campisi, J. (2022) · Aging Cell · doi:10.1111/acel.13750 · Cited by 28
Novel therapeutic approaches to target neurodegeneration
de la Fuente, A. G., Pelucchi, S., Mertens, J., Luca, M. D., Mauceri, D., & Marcello, E. E. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16078 · Cited by 33
“tributes to immune cell recruitment to eliminate senescent cells (Acosta et al., 2013).”
BackgroundRelationship between Obesity, Gut Microbiome and Hepatocellular Carcinoma Development
Hara, E. (2015) · Digestive Diseases · doi:10.1159/000371679 · Cited by 33
The Power Behind the Throne: Senescence and the Hallmarks of Cancer
Hoare, M., & Narita, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050352 · Cited by 33
de Galarreta, M. R., & Lujambio, A. (2017) · Nature Cell Biology · doi:10.1038/ncb3603 · Cited by 30
Size-scaling promotes senescence-like changes in proteome and organelle contentPreprint
Cheng, L., Chen, J., Kong, Y., Tan, C., Kafri, R., & Björklund, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.05.455193 · Cited by 34
Adulthood systemic inflammation accelerates the trajectory of age-related cognitive decline
Barter, J., Kumar, A., Bean, L. A., Ciesla, M. R., & Foster, T. C. (2021) · Aging · doi:10.18632/aging.203588 · Cited by 29
Cellular senescence is a key mediator of lung aging and susceptibility to infection
Torrance, B. L., & Haynes, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1006710 · Cited by 32
“Interestingly, this was linked to increased TGF-b (a known SASP factor) levels in the lung (8).”
BackgroundSkin Cancer Microenvironment: What We Can Learn from Skin Aging?
D’Arino, A., Caputo, S., Eibenschutz, L., Piemonte, P., Buccini, P., Frascione, P., & Bellei, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814043 · Cited by 36
“…acids, ceramides, cardiolipin, amyloid fibers, succinate, oxidized lipids, advanced glycation end-products, mitochondrial matrix portions, and mitochondria DNA) leading to inflammasome assembly, continuous secretion of several proinflammatory mediators and innate immune system recruitment [156,157].”
BackgroundWang, J., Zhang, M., & Wang, H. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00284 · Cited by 35
Etoh, K., Araki, H., Koga, T., Hino, Y., Kuribayashi, K., Hino, S., & Nakao, M. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114496 · Cited by 31
HiJAK’d Signaling; the STAT3 Paradox in Senescence and Cancer Progression
Junk, D. J., Bryson, B. L., & Jackson, M. W. (2014) · Cancers · doi:10.3390/cancers6020741 · Cited by 28
“The senescent cells, themselves, may then secrete additional cytokines that lead to a wide-spread senescence through a bystander effect [76–79].”
BackgroundHSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome
Martino, S. D., Amoreo, C. A., Nuvoli, B., Galati, R., Strano, S., Facciolo, F., Alessandrini, G., Pass, H. I., Ciliberto, G., Blandino, G., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0044-8 · Cited by 29
Hypoxia and the Metastatic Niche
Chan, C. Y., Yuen, V. W., & Wong, C. C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_7 · Cited by 30
Valenzuela, C. A., Quintanilla, R., Olate‐Briones, A., Venturini, W., Mancilla, D., Cayo, Á., Moore‐Carrasco, R., & Brown, N. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215292 · Cited by 30
Platelet Activation Is Triggered by Factors Secreted by Senescent Endothelial HMEC-1 Cells In Vitro
Venturini, W., Olate‐Briones, A., Valenzuela, C. A., Méndez, D., Eduardo Fuentes, Q., Cayo, Á., Mancilla, D., Segovia, R., Brown, N. E., & Moore‐Carrasco, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093287 · Cited by 32
“Thus, while some SASP components can propagate or reinforce cellular senescence [22,24,26,27], other components promote proliferation, migration or invasion of premalignant and malignant cells [23,25,28,29].”
BackgroundCallender, L. A., Carroll, E. C., Garrod-Ketchley, C., Schroth, J., Byström, J., Berryman, V., Pattrick, M., Campbell-Richards, D., Hood, G., Hitman, G. A., et al. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.681428 · Cited by 31
“This complex immune remodelling also includes the production of an inflammatory secretome called the senescence-associated secretory phenotype (SASP) (Acosta et al., 2013).”
BackgroundThorin‐Trescases, N., Labbé, P., Mury, P., Lambert, M., & Thorin, É. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212232 · Cited by 31
“Subsequently, unbiased proteomic studies identified the secretory profile of senescent fibroblasts, according to the inducer, in human cultured cells [63,92] and tissues [79,93].”
BackgroundNanoparticles-based anti-aging treatment of Alzheimer’s disease
Chu, J., Ji, W., Zhuang, J., Gong, B., Chen, X., Cheng, W., Liang, W., Li, G., Gao, J., & Yin, Y. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2094501 · Cited by 33
“Multiple components of SASP can also induce senescence of adjacent cells in a paracrine manner, resulting in the in vivo transmission of senescence (Acosta et al., 2013).”
BackgroundWhitehead, M., Yusoff, S., Ahmad, S., Schmidt, L. E., Mayr, M., Madine, J., Middleton, D. A., & Shanahan, C. M. (2022) · Aging Cell · doi:10.1111/acel.13746 · Cited by 33
“A hallmark of vascular ageing is the accumulation of senescent VSMCs, characterized by cell cycle arrest, DNA damage, and the secretion of inflammatory cytokines, growth factors and proteases (Acosta et al., 2013; Coppe et al., 2010).”
BackgroundThe cell secretome, a mediator of cell-to-cell communication
Zullo, J. A., Matsumoto, K., Xavier, S., Ratliff, B. B., & Goligorsky, M. S. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.03.012 · Cited by 38
Distinct secretomes in p16- and p21- positive senescent cells across tissues
Saul, D., Jurk, D., Doolittle, M. L., Kosinsky, R. L., Monroe, D. G., LeBrasseur, N. K., Robbins, P. D., Niedernhofer, L. J., Khosla, S., & Passos, J. F. (2023) · doi:10.1101/2023.12.05.569858 · Cited by 28
Wang, J., Zhou, X., Yu, P., Yao, J., Guo, P., Xu, Q., Zhao, Y., Wang, G., Li, Q., Zhu, X., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00886-2 · Cited by 28
“…proteins and other paracrine factors (such as transforming growth factor β (TGFβ) family ligands, vascular endothelial growth factor (VEGF) and chemokines) 2 , senescent cells can stimulate immune response and cell– cell communication, leading to pleiotropic effects in various tissues 3 .”
Fisetin, a potential skin rejuvenation drug that eliminates senescent cells in the dermis
Takaya, K., Asou, T., & Kishi, K. (2023) · Biogerontology · doi:10.1007/s10522-023-10064-9 · Cited by 38
“…inflammatory cytokines, growth factors, proteases, and chemokines called senescence-associated secretory phenotypes (SASPs) (Coppé et al. 2010; Acosta et al. 2013), in addition to exhibiting features such as the cytoplasmic expression of markers like p16ink4a, similar to tumor cells…”
Mitochondrial-related microRNAs and their roles in cellular senescence
Luo, L., An, X., Xiao, Y., Sun, X., Li, S., Wang, Y., Sun, W., & Yu, D. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2023.1279548 · Cited by 33
Inflammation and tumor immune escape in response to DNA damage
Nihira, N. T., Kudo, R., & Ohta, T. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.02.005 · Cited by 33
DNA Damage and Senescence-Associated Inflammation in Cardiovascular Disease
Ishida, T., Ishida, M., Tashiro, S., & Takeishi, Y. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00865 · Cited by 30
Exploiting the telomere machinery to put the brakes on inflamm-aging
Bonafè, M., Sabbatinelli, J., & Olivieri, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101027 · Cited by 31
Song, J., & Bae, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010406 · Cited by 32
“Because NF-κB is normally retained in the cytoplasm in a complex with IκB [6,8], cytoplasm and nuclei from cells transfected with CK2α siRNA or pcDNA-HA-CK2α were separated to examine the role of CK2 in the nuclear localization of RelA/p65.”
BackgroundHyperglycemia accelerates inflammaging in the gingival epithelium through inflammasomes activation
Zhang, P., Lu, B., Zhu, R., Yang, D., Liu, W., Wang, Q., Ji, N., Chen, Q., Ding, Y., Liang, X., et al. (2021) · Journal of Periodontal Research · doi:10.1111/jre.12863 · Cited by 31
Fibroblasts in cancer dormancy: foe or friend?
Dai, L., Mao, L., Zhang, W., Tang, Y.-J., Tang, Y., & Liang, X. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01883-2 · Cited by 28
“IOS fibroblasts can secrete TGF-β and IL-6 to induce neighboring cells into senescence, while in the meantime producing IL-1α, which in turn triggers SASP in a paracrine manner [76, 77].”
BackgroundThe Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity
Russo, M., Bono, E., & Ghigo, A. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00519-w · Cited by 28
Haraoka, Y., Akieda, Y., Nagai, Y., Mogi, C., & Ishitani, T. (2022) · Nature Communications · doi:10.1038/s41467-022-29061-6 · Cited by 28
Raynard, C., Ma, X., Huna, A., Tessier, N., Massemin, A., Zhu, K., Flaman, J., Moulin, F., Goehrig, D., Médard, J., et al. (2022) · Aging Cell · doi:10.1111/acel.13632 · Cited by 26
“The SASP is released from normal human fibroblasts exposed to classical stresses, either through the activation of oncogenic proteins (Acosta et al., 2013; Collin et al., 2018) or using genotoxic drugs (Contrepois et al., 2017), provoking their entry into senescence.”
BackgroundAccumulation of senescent cells in the stroma of aged mouse ovary
Maruyama, N., FUKUNAGA, I., Tomoaki, K. O. G. O., Endo, T., Fujii, W., Kanai‐Azuma, M., Naito, K., & Sugiura, K. (2023) · Journal of Reproduction and Development · doi:10.1262/jrd.2023-021 · Cited by 33
“For example, SASP factors, such as IL-1 and IL-6, produced by senescent human fibroblasts, act in a positive feedback loop to reinforce senescence [49, 50].”
BackgroundCellular lifespan and senescence: a complex balance between multiple cellular pathways
Dolivo, D., Hernandez, S. J., & Dominko, T. (2016) · BioEssays · doi:10.1002/bies.201670906 · Cited by 32
Vassilieva, I. O., Reshetnikova, G., Shatrova, A. N., Tsupkina, N. V., Харченко, М. В., Lp, A., Nikolsky, N. N., & Burova, E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.163 · Cited by 31
Chen, W., Wang, X., Wei, G., Huang, Y., Shi, Y., Li, D., Qiu, S., Zhou, B., Cao, J., Chen, M., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00867 · Cited by 26
Metadata
- Authors
- Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K. J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A. P., Carroll, T., Capper, D., Pritchard, C., Inman, G. J., Longerich, T., Sansom, O. J., Benitah, S. A., Zender, L., & Gil, J.
- Affiliations
- Imperial College London (GB)
- Centre for Genomic Regulation (ES)
- Cancer Research UK Scotland Institute (GB)
- University of Tübingen (DE)
- German Cancer Research Center (DE)
- University of Leicester (GB)
- University of Dundee (GB)
- Corresponding author
- Gil, Jesús
- ORCID
- Acosta, Juan Carlos
- Banito, Ana
- Janich, Peggy
- Morton, Jennifer P.
- Athineos, Dimitris
- Lasitschka, Felix
- Andrulis, Mindaugas
- Pascual, Gloria
- Khan, Sadaf
- Jin, Hong
- Snijders, Ambrosius P.
- Carroll, Thomas
- Capper, David
- Pritchard, Catrin
- Inman, Gareth J.
- Longerich, Thomas
- Sansom, Owen J.
- Benitah, Salvador Aznar
- Zender, Lars
- Gil, Jesús
- Venue
- Nature Cell Biology
- Published
- 2013-06-16
- Volume
- 15
- Issue
- 8
- Pages
- 978-990
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3732483
- OpenAlex
- W2140930678
- Semantic Scholar
- 59786bed7ce43f9317328cd82838f14d911e5dd4
- Cited by
- 2,278
- References
- 54
- Citations by year
- 2026: 247 · 2025: 225 · 2024: 232 · 2023: 240 · 2022: 264 · 2021: 250 · 2020: 202 · 2019: 154 · 2018: 119 · 2017: 107 · 2016: 89 · 2015: 79 · 2014: 56 · 2013: 13
- FWCI
- 54.88
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-28)
- Open access
- green
- europepmc.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- NERC Open Research Archive (Natural Environment Research Council) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Cancer Research UK (A7769, 13083, 11650, 12481)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- oncogene-induced senescence, senescence-associated secretory phenotype, paracrine senescence, inflammasome, IL-1 signaling, TGF-beta ligands, vascular endothelial growth factor, MCP-1, CCL20, CDKN2B, p21, tumor suppression, senescence-associated secretome
- MeSH terms
- Animals, Colonic Neoplasms, Humans, Immunohistochemistry, Interleukin-1, Protein Binding, Signal Transduction, Gene Expression Regulation, Neoplastic, Cellular Senescence, Paracrine Communication, Models, Animal, Cell Line, Tumor, Mice, Transforming Growth Factor beta1, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.